Pacira BioSciences, Inc.
PCRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$100 | $42 | $16 | $42 |
| Dep. & Amort. | $79 | $76 | $92 | $29 |
| Deferred Tax | $21 | $16 | -$8 | $11 |
| Stock-Based Comp. | $51 | $48 | $0 | $42 |
| Change in WC | -$19 | -$46 | -$16 | -$19 |
| Other Non-Cash | $157 | $19 | $62 | $21 |
| Operating Cash Flow | $189 | $155 | $145 | $126 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$15 | -$30 | -$46 |
| Net Acquisitions | $0 | $0 | $0 | -$420 |
| Inv. Purchases | -$252 | -$144 | -$401 | -$629 |
| Inv. Sales/Matur. | $180 | $237 | $238 | $1,078 |
| Other Inv. Act. | $0 | $0 | -$32 | -$4 |
| Investing Cash Flow | -$83 | $78 | -$225 | -$21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $77 | -$181 | -$428 | $364 |
| Stock Issued | $0 | $0 | $27 | $0 |
| Stock Repurch. | -$25 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$34 | -$2 | -$1 | $17 |
| Financing Cash Flow | $17 | -$183 | -$402 | $381 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $123 | $49 | -$481 | $486 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $153 | $104 | $586 | $100 |
| End Cash | $277 | $153 | $104 | $586 |
| Free Cash Flow | $179 | $139 | $115 | $80 |